M Joice1, G I Vasileiadis2, D F Amanatullah3. 1. Albert Einstein College of Medicine, New York, New York, USA. 2. Mayo Clinic Department of Physical Medicine and Rehabilitation, Rochester, Minnesota, USA. 3. Stanford Hospital and Clinics, Redwood City, California, USA.
Abstract
Aims: The aim of this study was to assess the efficacy of non-selective and selective non-steroidal anti-inflammatory drugs (NSAIDs) in preventing heterotopic ossification (HO) after total hip arthroplasty (THA). Methods: A thorough and systematic literature search was conducted and 29 studies were found that met inclusion criteria. Data were extracted and statistical analysis was carried out generating forest plots. Results: Non-selective NSAIDs showed a significant decrease in the odds for forming HO after THA (odds ratio (OR) -1.35, confidence interval (CI) -1.83 to -0.86) when compared with placebo. Selective NSAIDs also showed a significant decrease in the odds for forming HO after THA when compared with placebo (OR -1.58, CI -2.41 to -0.75). When comparing non-selective NSAIDs with selective NSAIDs, there was no significant change in the odds for forming HO after THA (OR 0.22, CI -0.36 to 0.79). Conclusion: Our meta-analyses of all available data suggest that both non-selective and selective NSAIDs are effective HO prophylaxis and can be used routinely after THA for pain control as well as prevention of HO. Indomethacin may serve as the benchmark among non-selective NSAIDs and celecoxib among selective NSAIDs. There was no difference in the incidence of HO between non-selective and selective NSAIDs, allowing physicians to choose either based on the clinical scenario and patient-specific factors. Cite this article: Bone Joint J 2018;100-B:915-22.
Aims: The aim of this study was to assess the efficacy of non-selective and selective non-steroidal anti-inflammatory drugs (NSAIDs) in preventing heterotopic ossification (HO) after total hip arthroplasty (THA). Methods: A thorough and systematic literature search was conducted and 29 studies were found that met inclusion criteria. Data were extracted and statistical analysis was carried out generating forest plots. Results: Non-selective NSAIDs showed a significant decrease in the odds for forming HO after THA (odds ratio (OR) -1.35, confidence interval (CI) -1.83 to -0.86) when compared with placebo. Selective NSAIDs also showed a significant decrease in the odds for forming HO after THA when compared with placebo (OR -1.58, CI -2.41 to -0.75). When comparing non-selective NSAIDs with selective NSAIDs, there was no significant change in the odds for forming HO after THA (OR 0.22, CI -0.36 to 0.79). Conclusion: Our meta-analyses of all available data suggest that both non-selective and selective NSAIDs are effective HO prophylaxis and can be used routinely after THA for pain control as well as prevention of HO. Indomethacin may serve as the benchmark among non-selective NSAIDs and celecoxib among selective NSAIDs. There was no difference in the incidence of HO between non-selective and selective NSAIDs, allowing physicians to choose either based on the clinical scenario and patient-specific factors. Cite this article: Bone Joint J 2018;100-B:915-22.
Entities:
Keywords:
Heterotopic ossification; NSAIDs; Prophylaxis; Total hip arthroplasty
Authors: Tomasz Stołtny; Jarosław Pasek; Dominika Rokicka; Marta Wróbel; Michał Dobrakowski; Paweł Kamiński; Rafał Domagalski; Szymon Czech; Krzysztof Strojek; Bogdan Koczy Journal: J Int Med Res Date: 2022-06 Impact factor: 1.573
Authors: Favour Felix-Ilemhenbhio; George A E Pickering; Endre Kiss-Toth; Jeremy Mark Wilkinson Journal: Int J Mol Sci Date: 2022-06-23 Impact factor: 6.208
Authors: Marianne Comeau-Gauthier; Robert D Zura; Sofia Bzovsky; Emil H Schemitsch; Daniel Axelrod; Victoria Avram; Ajay Manjoo; Rudolf W Poolman; Frede Frihagen; Diane Heels-Ansdell; Mohit Bhandari; Sheila Sprague Journal: J Bone Joint Surg Am Date: 2021-07-21 Impact factor: 6.558
Authors: Mohammad M Al-Qattan; Ahmad A Al-Boukai; Yasir AlShehri; Yazeed A AlSaadi; Hisham M A Elaaqip; Ali H Alassiri Journal: Int J Surg Case Rep Date: 2020-02-25